Affordable Access

The rho-kinase inhibitors Y-27632 and fasudil act synergistically with imatinib to inhibit the expansion of ex vivo CD34(+) CML progenitor cells.

Authors
Type
Published Article
Journal
Leukemia
Publication Date
Volume
21
Issue
8
Pages
1708–1714
Identifiers
PMID: 17554385
Source
Medline

Abstract

Statistics

Seen <100 times